uu.seUppsala universitets publikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Innovative strategy for 3D transfection of primary human stem cells with BMP-2 expressing plasmid DNA: A clinically translatable strategy for ex vivogene therapy
Uppsala universitet, Teknisk-naturvetenskapliga vetenskapsområdet, Kemiska sektionen, Institutionen för kemi - Ångström, Polymerkemi. (Tanslational Chemical Biology Laboratory)ORCID-id: 0000-0003-2896-2765
Uppsala universitet, Teknisk-naturvetenskapliga vetenskapsområdet, Kemiska sektionen, Institutionen för kemi - Ångström, Polymerkemi. (Tanslational Chemical Biology Laboratory)
Uppsala universitet, Teknisk-naturvetenskapliga vetenskapsområdet, Kemiska sektionen, Institutionen för kemi - Ångström, Polymerkemi. (Translational Chemical Biology Laboratory)
2019 (Engelska)Ingår i: International Journal of Molecular Sciences, ISSN 1422-0067, E-ISSN 1422-0067, Vol. 20, nr 1, artikel-id 56Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

Ex vivo gene therapy offers enormous potential for cell-based therapies, however, cumbersome in vitro cell culture conditions have limited its use in clinical practice. We have optimized an innovative strategy for the transient transfection of bone morphogenetic protein-2 (BMP-2) expressing plasmids in suspended human stem cells within 5-min that enables efficient loading of the transfected cells into a 3D hydrogel system. Such a short incubation time for lipid-based DNA nanoparticles (lipoplexes) reduces cytotoxicity and at the same time reduces the processing time for cells to be transplanted. The encapsulated human mesenchymal stromal/stem cells (hMSCs) transfected with BMP-2 plasmid demonstrated high expression of an osteogenic transcription factor, namely RUNX2, but not the chondrogenic factor (SOX9), within the first three days. This activation was also reflected in the 7-day and 21-day experiment, which clearly indicated the induction of osteogenesis but not chondrogenesis. We believe our transient transfection method demonstrated in primary MSCs can be adapted for other therapeutic genes for different cell-based therapeutic applications.

Ort, förlag, år, upplaga, sidor
Basel, Switzerland: MDPI, 2019. Vol. 20, nr 1, artikel-id 56
Nyckelord [en]
hydrogel; DNA; transfection; ex vivo; hyaluronic acid
Nationell ämneskategori
Biomaterialvetenskap
Identifikatorer
URN: urn:nbn:se:uu:diva-369655DOI: 10.3390/ijms20010056ISI: 000459747700056PubMedID: 30583610OAI: oai:DiVA.org:uu-369655DiVA, id: diva2:1271016
Forskningsfinansiär
EU, FP7, Sjunde ramprogrammet, FP7/2007-2013/607868Stiftelsen för strategisk forskning (SSF), SBE13-0028Tillgänglig från: 2018-12-14 Skapad: 2018-12-14 Senast uppdaterad: 2019-03-18Bibliografiskt granskad
Ingår i avhandling
1. Regulating Gene Expression to Promote Osteoblastic Differentiation of Stem Cells
Öppna denna publikation i ny flik eller fönster >>Regulating Gene Expression to Promote Osteoblastic Differentiation of Stem Cells
2019 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Bone is a tissue that heals by itself, unless the defect is too large (critical size). Today, novel regenerative medicine approaches have emerged as an alternative to treat such defects. This thesis explores alternative therapeutic strategies for bone tissue engineering which are biocompatible and clinically translatable. Many types of scaffolds that can act as reservoirs for growth factors such as rh-BMP-2 have been developed for bone tissue engineering in the past. However, the role of cross-linking chemistries that are employed to make hydrogels on the integrity and function of the loaded growth factors is not well understood. In this thesis, we have explored the influence of cross-linking chemistry on rh-BMP-2 integrity and bioactivity both in-vitro and in-vivo. These studies have demonstrated that thiol-Michael addition cross-linking chemistry greatly affects the integrity and bio-functionality of the loaded protein BMP-2 and leads to poor bone formation in an in-vivo rat model. On the other hand, hydrogels employing hydrazone chemistry did not significantly affect the integrity and bioactivity of BMP-2, which lead to a superior bone formation in-vivo. Since the high dose of rh-BMP-2 is known to confer many side effects, alternative ex-vivo strategies involving transient transfection of BMP-2 expressing plasmid DNA and silencing of anti-osteogenic genes using siRNA are developed. Our optimized method involves rapid transfection of hMSCs in suspension (5 minutes) with plasmid DNA followed by centrifugation and encapsulation in a hydrogel not only reduced cytotoxicity but also lead to efficient osteoblast differentiation of stem cells. Furthermore, this thesis presents the role of ECM-derived polymer HA in interacting with siRNA and trafficking across the plasma membrane, presumably through CD44 receptors and successfully silencing the target gene in-vitro. We explored the potential of such a non-cationic transfection method to deliver functional siRNA (anti-Pleckho-1 siRNA) in MSCs and compared it with commercially available cationic lipid LipofectamineTMRNAiMAX, using our optimized suspension transfection method. Our novel ex-vivo strategy employing HA hydrogels enabled efficient silencing of BMP-2 signaling pathway antagonist Pleckho-1 while avoiding the cytotoxicity issues in 3D, which further qualifies them for potential clinical application for cell-based therapies. 

Ort, förlag, år, upplaga, sidor
Uppsala: Acta Universitatis Upsaliensis, 2019. s. 106
Serie
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology, ISSN 1651-6214 ; 1758
Nationell ämneskategori
Polymerkemi
Forskningsämne
Kemi med inriktning mot polymerkemi
Identifikatorer
urn:nbn:se:uu:diva-369660 (URN)978-91-513-0540-0 (ISBN)
Disputation
2019-02-13, Häggsalen, Ångströmlaboratoriet, Lägerhyddsvägen 1, Uppsala, 13:15 (Engelska)
Opponent
Handledare
Tillgänglig från: 2019-01-23 Skapad: 2018-12-15 Senast uppdaterad: 2019-02-18

Open Access i DiVA

fulltext(3922 kB)72 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 3922 kBChecksumma SHA-512
3636c6b7ed8b919712425a943bb76894dca6086ea6a812eee14a369bda3904365e532499c6967269fd139e4332e5245d7345648f78fa85a34f2768d103016df5
Typ fulltextMimetyp application/pdf
SI info(527 kB)0 nedladdningar
Filinformation
Filnamn ATTACHMENT01.pdfFilstorlek 527 kBChecksumma SHA-512
00eadb4f64e9ab0d1a54318fa7f7cd3ce1198f993a5ec70c9222926b1849b1841def47d2ef39fadd4b22c9cb0d132d4efdb87585218a786b8e9d594d38d7d56e
Typ attachmentMimetyp application/pdf

Övriga länkar

Förlagets fulltextPubMed

Personposter BETA

Paidikondala, MaruthibabuKadekar, SandeepVarghese, Oommen P.

Sök vidare i DiVA

Av författaren/redaktören
Paidikondala, MaruthibabuKadekar, SandeepVarghese, Oommen P.
Av organisationen
Polymerkemi
I samma tidskrift
International Journal of Molecular Sciences
Biomaterialvetenskap

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 72 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 109 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf